Bromelain Supplement for Reducing Facial Swelling After Jaw Surgery
Bromelain
Malocclusion
+ Stomatognathic Diseases
+ Tooth Diseases
Supportive Care Study
Summary
Study start date: September 8, 2025
Actual date on which the first participant was enrolled.This clinical trial is focused on evaluating the effectiveness of a supplement called Bromelain in reducing facial swelling that often occurs after jaw surgery, also known as orthognathic surgery. The study aims to understand whether Bromelain can lessen the amount of swelling and shorten the duration of swelling following the surgery. This is significant as reducing swelling can improve recovery experiences for patients undergoing this type of surgery. Participants in the study will take a Bromelain supplement once daily for a total of nine days. They will start taking it two days before their surgery and continue for seven days after the surgery. Participants are required to keep a record of when they take the Bromelain supplement and any other medications. They will also attend clinic visits to follow specific procedures before and after the surgery. This study will help determine the safety and effectiveness of Bromelain in managing post-surgical swelling.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.200 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Supportive Care Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 65 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location